Kensington Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Hold
2,041
1.06% 29
2026
Q1
$1.88M Hold
2,041
0.9% 35
2025
Q4
$2.19M Buy
2,041
+30
+1% +$28.7K 0.89% 36
2025
Q3
$1.53M Hold
2,011
0.63% 49
2025
Q2
$1.57M Hold
2,011
0.67% 47
2025
Q1
$1.66M Hold
2,011
0.74% 43
2024
Q4
$1.55M Sell
2,011
-30
-1% -$24.8K 0.65% 51
2024
Q3
$1.81M Sell
2,041
-20
-1% -$18K 0.76% 46
2024
Q2
$1.87M Sell
2,061
-11
-0.5% -$8.8K 0.83% 44
2024
Q1
$1.61M Hold
2,072
0.74% 50
2023
Q4
$1.21M Sell
2,072
-104
-5% -$60.7K 0.63% 56
2023
Q3
$1.17M Buy
2,176
+126
+6% +$64.9K 0.73% 53
2023
Q2
$961K Buy
+2,050
New +$860K 0.61% 60

Other funds holding LLY

Kensington Investment Counsel's LLY Position: Q2 2026 in Review

Kensington Investment Counsel held its Eli Lilly (LLY) position steady in Q2 2026 at 2,041 shares worth $2.45M. The position accounts for 1.06% of the portfolio, ranked #29.

Kensington Investment Counsel first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kensington Investment Counsel held 2,041 shares of Eli Lilly worth $2.45M as of Q2 2026.
  • Kensington Investment Counsel left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.06% of Kensington Investment Counsel's portfolio in Q2 2026, its #29 holding.
  • Kensington Investment Counsel first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kensington Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.